Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clopidogrel paclitaxel drug-drug interaction:A pharmacoepidemiologic study

Autor: Tore Bjerregaard Stage, Kim Brøsen, K. Agergaard, Karina Dahl Steffensen, Troels K Bergmann, R.E. Hassel, M.L.H. Milo, J.W. Pedersen, Jesper Hallas, Trine Lembrecht Jørgensen, Morten Mau-Sørensen, S.H. Poulsen, Anton Pottegård

Publikováno v: Agergaard, K, Mau-Sørensen, M, Bjerregaard Stage, T, Jørgensen, T L, Hassel, R E, Steffensen, K D, Pedersen, J W, Milo, M L H, Poulsen, S H, Pottegård, A, Hallas, J, Brøsen, K & Bergmann, T K 2017, ' Clopidogrel paclitaxel drug-drug interaction : A pharmacoepidemiologic study ', Clinical Pharmacology and Therapeutics, vol. 102, no. 3, pp. 547-553 . https://doi.org/10.1002/cpt.674
Agergaard, K, Mau-Sørensen, M, Stage, T B, Jørgensen, T L, Hassel, R E, Dahl Steffensen, K, Pedersen, J W, Milo, M L H, Poulsen, S H, Pottegård, A, Hallas, J, Brøsen, K & Bergmann, T K 2017, ' Clopidogrel paclitaxel drug-drug interaction : A pharmacoepidemiologic study ', Clinical Pharmacology and Therapeutics, vol. 102, no. 3, pp. 547–553 . https://doi.org/10.1002/cpt.674
Agergaard, K, Mau-Sørensen, M, Stage, T B, Jørgensen, T L, Hassel, R E, Steffensen, K D, Pedersen, J W, Milo, M, Poulsen, S H, Pottegård, A, Hallas, J, Brøsen, K & Bergmann, T K 2017, ' Clopidogrel-Paclitaxel Drug-Drug Interaction : A Pharmacoepidemiologic Study ', Clinical Pharmacology and Therapeutics, vol. 102, no. 3, pp. 547-553 . https://doi.org/10.1002/cpt.674

Paclitaxel is mainly eliminated by CYP2C8 in the liver. CYP2C8 is strongly inhibited by the clopidogrel metabolite acyl-β-D-glucuronide. To determine if this interaction has clinical relevance, we identified 48 patients treated with clopidogrel and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d038021f6f01fd3356c76629d7942059
https://vbn.aau.dk/da/publications/d5968a99-ec29-4264-a97a-1f2816cb0e00

New Drug Interaction: Clopidogrel Associated with Paclitaxel Induced Neuropathy in Cancer Patients

Autor: Tore Bjerregaard Stage, Anton Pottegård, Karina Dahl Steffensen, S.H. Poulsen, Troels K Bergmann, J.W. Pedersen, M.L.H. Milo, R.E. Hassel, Jesper Hallas, Trine Lembrecht Jørgensen, Kim Brøsen, K. Agergaard, Morten Mau-Sørensen

Publikováno v: Clinical Therapeutics. 39:e61

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2aaa4ceef507857b119eaf8b2db72623
https://doi.org/10.1016/j.clinthera.2017.05.189

supportive care Influence of concomitant clopidogrel consumption on development of paclitaxel-associated toxicity: A pharmacoepidemiological study

Autor: K. Agergaard, M. Mau-Sørensen, T.B. Stage, T.L. Jørgensen, R.E. Hassel, K.D. Steffensen, J.W. Pedersen, M.L.H. Milo, S.H. Poulsen, A. Pottegård, J. Hallas, K. Brøsen, T.K. Bergmann

Publikováno v: Annals of Oncology. 27:vi587

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c247fcea06b920f924c8c1c6d485254f
https://doi.org/10.1093/annonc/mdw435.53

A compact integrated InP-based single-phasar optical crossconnect

Autor: D.H.P. Maat, Xaveer Leijtens, Cgm Vreeburg, FH Groen, C.G.P. Herben, J.W. Pedersen, Piet Demeester, Ys Oei, MK Meint Smit

Publikováno v: IEEE Photonics Technology Letters. 10:678-680

The first integrated InP-based polarization independent optical crossconnect is reported. The device can crossconnect signals at four wavelengths independently from two input fibers to two output fibers. Total on-chip loss is less then 16 dB. Device

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71ce70ee1a29a4b3a7012e72c65bcec1
https://doi.org/10.1109/68.669247